37.11
-0.16(-0.43%)
Currency In USD
| Previous Close | 37.27 |
| Open | 37.1 |
| Day High | 37.49 |
| Day Low | 36.85 |
| 52-Week High | 37.57 |
| 52-Week Low | 24.05 |
| Volume | 1.44M |
| Average Volume | 4.51M |
| Market Cap | 20.87B |
| PE | 15.15 |
| EPS | 2.45 |
| Moving Average 50 Days | 34.89 |
| Moving Average 200 Days | 31.04 |
| Change | -0.16 |
If you invested $1000 in Royalty Pharma plc (RPRX) since IPO date, it would be worth $923.67 as of July 30, 2025 at a share price of $37.27. Whereas If you bought $1000 worth of Royalty Pharma plc (RPRX) shares 2 years ago, it would be worth $929.89 as of July 30, 2025 at a share price of $37.27.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Royalty Pharma Declares Third Quarter 2025 Dividend
GlobeNewswire Inc.
Jul 18, 2025 12:15 PM GMT
NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2025 of $0.22 per Class A ordinary share. The dividend will be paid on September
Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors
GlobeNewswire Inc.
Jul 17, 2025 12:15 PM GMT
Strengthens Board of Directors with appointment of two new independent members, increasing independent representation to greater than 90%Underscores Royalty Pharma’s commitment to enhanced corporate governance following acquisition of its external ma
Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire Inc.
Jul 16, 2025 8:15 PM GMT
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2025 financial results on Wednesday, August 6, 2025 before the U.S. financial markets open. The company will host a